Extraintestinal manifestations of inflammatory bowel disease

被引:58
|
作者
Jose, Folashade A. [1 ]
Heyman, Melvin B. [2 ]
机构
[1] Univ Calif San Francisco, Dept Pediat Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
关键词
colitis; Crohn disease; erythema nodosum; growth; pediatric; sclerosing cholangitis; thromboses;
D O I
10.1097/MPG.0b013e318093f4b0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
UC and CD commonly manifest signs and symptoms of extraintestinal disease. Patients with evidence of disease extrinsic to the gastrointestinal tract should be considered to have an associated complication of their underlying IBD. Patients with persistent signs or symptoms of EIMs should be evaluated for IBD if not previously diagnosed. Data on EIMs of IBD in children are lacking compared with those in adults (Table 2), and may be revealing in light of recent studies suggesting unique aspects of early-onset IBD compared with older patients (91,92). Information pertaining to the incidence and prevalence of EIMs of IBD in children is essential to improve our understanding of the natural history and associated EIMs in children with IBD. Copyright © 2007 by Lippincott Williams & Wilkins.
引用
收藏
页码:124 / 133
页数:10
相关论文
共 50 条
  • [31] Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking
    Roberts, Henry
    Rai, Shesh N.
    Pan, Jianmin
    Rao, J. Michael
    Keskey, Robert C.
    Kanaan, Ziad
    Short, Ethan P.
    Mottern, Edward
    Galandiuk, Susan
    [J]. DIGESTION, 2014, 90 (02) : 122 - 129
  • [33] Treatment of the extraintestinal manifestations of inflammatory bowel disease.
    Bernstein C.N.
    [J]. Current Gastroenterology Reports, 2002, 4 (6) : 513 - 516
  • [34] Extraintestinal manifestations in paediatric patients with inflammatory bowel disease
    Shentova-Eneva, R.
    Baycheva, M.
    Hadjiiski, P.
    Kofinova, D.
    Yaneva, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S236 - S237
  • [35] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S32 - S33
  • [36] Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fedor, Istvan
    Zold, Eva
    Barta, Zsolt
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [37] Update in the management of extraintestinal manifestations of inflammatory bowel disease
    Patil S.A.
    Cross R.K.
    [J]. Current Gastroenterology Reports, 2013, 15 (3)
  • [38] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [39] ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Gordon, Hannah
    Burisch, Johan
    Ellul, Pierre
    Karmiris, Konstantinos
    Katsanos, Konstantinos
    Allocca, Mariangela
    Bamias, Giorgos
    Barreiro-de Acosta, Manuel
    Braithwaite, Tasanee
    Greuter, Thomas
    Harwood, Catherine
    Juillerat, Pascal
    Lobaton, Triana
    Mueller-Ladner, Ulf
    Noor, Nurulamin
    Pellino, Gianluca
    Savarino, Edoardo
    Schramm, Christoph
    Soriano, Alessandra
    Stein, Juergen Michael
    Uzzan, Mathieu
    van Rheenen, Patrick F.
    Vavricka, Stephan R.
    Vecchi, Maurizio
    Zuily, Stephane
    Kucharzik, Torsten
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 1 - 37
  • [40] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675